Literature DB >> 33563016

D-Dimer as Predictor of Large Vessel Occlusion in Acute Ischemic Stroke.

Anna Ramos-Pachón1, Elena López-Cancio2, Alejandro Bustamante1, Natàlia Pérez de la Ossa1, Mònica Millán1, Maria Hernández-Pérez1, Teresa Garcia-Berrocoso3, Pere Cardona4, Marta Rubiera5, Joaquín Serena6, Xavier Ustrell7, Moisés Garcés8, Mikel Terceño6, Antoni Dávalos1, Joan Montaner1,3.   

Abstract

BACKGROUND AND
PURPOSE: Improving prehospital triage of large vessel occlusion (LVO) would reduce time to reperfusion therapies. We aimed to study early predictors of LVO in acute ischemic stroke to identify candidates for endovascular treatment.
METHODS: The Stroke-Chip was a prospective observational study conducted at 6 Stroke Centers in Catalonia. Blood samples were obtained in the first 6 hours from symptom onset of consecutive patients. Stroke severity was evaluated with National Institutes of Health Stroke Scale (NIHSS) and LVO was assessed. Independent association of multiple blood biomarkers with LVO was evaluated using logistic regression models adjusted by covariates. Sensitivity, specificity, and predictive values were assessed for NIHSS and the combination of NIHSS and selected serum biomarkers levels.
RESULTS: One thousand three hundred eight suspected strokes were enrolled for a 17-month period. LVO was not assessed in 131 patients. One thousand one hundred seventy-seven patients were selected for analysis (mean age 69.3 years, 56% men, median baseline NIHSS of 6, and median time to blood collection 2.5 hours). LVO was detected in 262 patients. LVO patients were older, had higher baseline NIHSS, history of atrial fibrillation, and lower time from stroke onset to admission. After logistic regression analysis, D-dimer remained an independent predictor of LVO (odds ratio, 1.59 [1.31-1.92]). Specificity and positive predictive value to exclude or detect LVO were higher when using combined D-dimer levels and NIHSS score assessment rather than NIHSS alone.
CONCLUSIONS: Early D-dimer levels are an independent predictor of LVO and may be useful to better optimize prehospital patient transport to the appropriate stroke center.

Entities:  

Keywords:  biomarkers; patients; reperfusion; stroke; thrombectomy

Mesh:

Substances:

Year:  2021        PMID: 33563016     DOI: 10.1161/STROKEAHA.120.031657

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  6 in total

1.  Acute Middle Cerebral Artery Occlusion Detection Using Mobile Non-Imaging Brain Perfusion Ultrasound-First Case.

Authors:  Mustafa Kilic; Christina Wendl; Sibylle Wilfling; David Olmes; Ralf Andreas Linker; Felix Schlachetzki
Journal:  J Clin Med       Date:  2022-06-13       Impact factor: 4.964

2.  Potential Biomarkers to Predict Acute Ischemic Stroke in Type 2 Diabetes.

Authors:  Abu Saleh Md Moin; Manjula Nandakumar; Ahmed Al-Qaissi; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Front Mol Biosci       Date:  2021-12-01

3.  Optimization of Large Vessel Occlusion Detection in Acute Ischemic Stroke Using Machine Learning Methods.

Authors:  Gabor Tarkanyi; Akos Tenyi; Roland Hollos; Peter Janos Kalmar; Laszlo Szapary
Journal:  Life (Basel)       Date:  2022-02-03

4.  Streamlining Acute Stroke Care by Introducing National Institutes of Health Stroke Scale in the Emergency Medical Services: A Prospective Cohort Study.

Authors:  Karianne Larsen; Henriette S Jæger; Maren R Hov; Kjetil Thorsen; Volker Solyga; Christian G Lund; Kristi G Bache
Journal:  Stroke       Date:  2022-03-16       Impact factor: 10.170

5.  Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study.

Authors:  Yunfei Wei; Shiting Tang; Zhouhua Xie; Yaoqin He; Yunli Zhang; Yiju Xie; Shijian Chen; Liuyu Liu; Yayuan Liu; Zhijian Liang
Journal:  J Inflamm Res       Date:  2022-07-26

6.  Neutrophil count multiplied by D-dimer combined with pneumonia may better predict short-term outcomes in patients with acute ischemic stroke.

Authors:  Yinting Xing; Wei Yang; Yingyu Jin; Yanhong Liu
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.